Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-02-02 @ 5:39 AM
Study NCT ID:
NCT03841734
Status:
UNKNOWN
Last Update Posted:
2019-02-15
First Post:
2019-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
Sponsor:
Centre Hospitalier Universitaire de Nice
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2019-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-03
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-05
First Submit QC Date:
None
Study First Post Date:
2019-02-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-13
Last Update Post Date:
2019-02-15
Last Update Post Date Type:
ACTUAL